{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:19:04Z","timestamp":1778923144709,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Roentgenology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1053\/j.ro.2013.03.017","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T13:31:13Z","timestamp":1378992673000},"page":"323-334","source":"Crossref","is-referenced-by-count":41,"title":["Malignant Pleural Mesothelioma: Role of CT, MRI, and PET\/CT in Staging Evaluation and Treatment Considerations"],"prefix":"10.1053","volume":"48","author":[{"given":"Mylene T.","family":"Truong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrna B.C.","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett W.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith M.","family":"Marom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ro.2013.03.017_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.semtcvs.2009.07.005","article-title":"Multimodality management of malignant pleural mesothelioma: Introduction","volume":"21","author":"Sugarbaker","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib3","doi-asserted-by":"crossref","first-page":"272S","DOI":"10.1378\/chest.112.4_Supplement.272S","article-title":"Multimodality therapy for malignant pleural mesothelioma","volume":"112","author":"Sugarbaker","year":"1997","journal-title":"Chest"},{"key":"10.1053\/j.ro.2013.03.017_bib4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/1097-0142(19801001)46:7<1650::AID-CNCR2820460726>3.0.CO;2-Y","article-title":"Malignant mesothelioma in North America","volume":"46","author":"McDonald","year":"1980","journal-title":"Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib6","first-page":"182","article-title":"Malignant mesothelioma in a cohort of asbestos insulation workers: Clinical presentation, diagnosis, and causes of death","volume":"45","author":"Ribak","year":"1988","journal-title":"Br J Ind Med"},{"key":"10.1053\/j.ro.2013.03.017_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/annhyg\/44.8.565","article-title":"The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure","volume":"44","author":"Hodgson","year":"2000","journal-title":"Ann Occup Hyg"},{"key":"10.1053\/j.ro.2013.03.017_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: Global incidence and relationship with asbestos","volume":"45","author":"Bianchi","year":"2007","journal-title":"Ind Health"},{"key":"10.1053\/j.ro.2013.03.017_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/107327480601300402","article-title":"Malignant pleural mesothelioma: A comprehensive review","volume":"13","author":"Ismail-Khan","year":"2006","journal-title":"Cancer Control"},{"key":"10.1053\/j.ro.2013.03.017_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nrc947","article-title":"SV40 and human tumours: Myth, association or causality?","volume":"2","author":"Gazdar","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2559.1997.5460776.x","article-title":"Pathology of malignant mesothelioma","volume":"30","author":"Attanoos","year":"1997","journal-title":"Histopathology"},{"key":"10.1053\/j.ro.2013.03.017_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.semtcvs.2009.06.005","article-title":"Pathologic evaluation of malignant pleural mesothelioma","volume":"21","author":"Chirieac","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5","article-title":"Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients Part 2: Prognosis and staging","volume":"72","author":"Boutin","year":"1993","journal-title":"Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00004728-199505000-00006","article-title":"CT-guided pleural needle biopsy in the diagnosis of malignant mesothelioma","volume":"19","author":"Metintas","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.ro.2013.03.017_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02306613","article-title":"Surgically debulked malignant pleural mesothelioma: Results and prognostic factors","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2214\/ajr.154.3.2106209","article-title":"CT in differential diagnosis of diffuse pleural disease","volume":"154","author":"Leung","year":"1990","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.ro.2013.03.017_bib17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"10.1053\/j.ro.2013.03.017_bib18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the International Association for the Study of Lung Cancer Mesothelioma Database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib19","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.athoracsur.2005.06.014","article-title":"Extended surgical staging for potentially resectable malignant pleural mesothelioma","volume":"80","author":"Rice","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-5223(19)35312-7","article-title":"The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma","volume":"96","author":"Rusch","year":"1988","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semtcvs.2009.07.007","article-title":"Surgical techniques for multimodality treatment of malignant pleural mesothelioma: Extrapleural pneumonectomy and pleurectomy\/decortication","volume":"21","author":"Wolf","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0003-4975(03)00010-9","article-title":"The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma","volume":"75","author":"Schouwink","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/108497804323071913","article-title":"Role of 18F-FDG PET for evaluating malignant pleural mesothelioma","volume":"19","author":"Nanni","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.ro.2013.03.017_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mtc.2000.106529","article-title":"Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma","volume":"120","author":"Schneider","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1378\/chest.114.3.713","article-title":"Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography","volume":"114","author":"Benard","year":"1998","journal-title":"Chest"},{"issue":"suppl 1","key":"10.1053\/j.ro.2013.03.017_bib27","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.lungcan.2005.03.007","article-title":"The role of PET in the surgical management of malignant pleural mesothelioma","volume":"49","author":"Flores","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2004.10.034","article-title":"Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications","volume":"129","author":"Erasmus","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib29","first-page":"283","article-title":"The radiology of thoracic malignant mesothelioma","volume":"20","author":"Wechsler","year":"1984","journal-title":"Crit Rev Diagn Imaging"},{"key":"10.1053\/j.ro.2013.03.017_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2214\/ajr.155.5.2120965","article-title":"Malignant pleural mesothelioma: CT manifestations in 50 cases","volume":"155","author":"Kawashima","year":"1990","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.ro.2013.03.017_bib31","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2214\/ajr.159.5.1414807","article-title":"Malignant pleural mesothelioma: Value of CT and MR imaging in predicting resectability","volume":"159","author":"Patz","year":"1992","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.ro.2013.03.017_bib32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2214\/ajr.172.4.10587144","article-title":"Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging","volume":"172","author":"Heelan","year":"1999","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.ro.2013.03.017_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-5223(03)00207-1","article-title":"Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma","volume":"126","author":"Flores","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib34","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/JTO.0b013e3181c0a7ff","article-title":"Clinical value of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: An observational pilot study","volume":"4","author":"Yildirim","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/RLI.0b013e3181817b3d","article-title":"Computed tomography, positron emission tomography, positron emission tomography\/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: Initial results","volume":"43","author":"Plathow","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1053\/j.ro.2013.03.017_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3816\/CLC.2009.n.033","article-title":"Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma","volume":"10","author":"Wilcox","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib37","first-page":"111","article-title":"Additional value of hybrid PET\/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma","volume":"8","author":"Ambrosini","year":"2005","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1053\/j.ro.2013.03.017_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1183\/09031936.98.12040972","article-title":"Malignant pleural mesothelioma","volume":"12","author":"Boutin","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1053\/j.ro.2013.03.017_bib39","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib40","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","article-title":"Trimodality therapy for malignant pleural mesothelioma: Results from an EORTC phase II multicentre trial","volume":"36","author":"Van Schil","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1053\/j.ro.2013.03.017_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib42","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/ers.10.35","article-title":"Surgery for malignant pleural mesothelioma","volume":"4","author":"Sugarbaker","year":"2010","journal-title":"Expert Rev Respir Med"},{"key":"10.1053\/j.ro.2013.03.017_bib43","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"key":"10.1053\/j.ro.2013.03.017_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2007.05.022","article-title":"A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma","volume":"84","author":"O'Rourke","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib45","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.athoracsur.2007.04.076","article-title":"Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"84","author":"Rice","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.ro.2013.03.017_bib47","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bjc.1990.207","article-title":"Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody","volume":"61","author":"Dazzi","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib48","first-page":"3200","article-title":"Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo","volume":"57","author":"Marzo","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/j.ro.2013.03.017_bib49","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.ejca.2006.07.011","article-title":"Biology and management of malignant pleural mesothelioma","volume":"42","author":"Zucali","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib50","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib51","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1378\/chest.08-2665","article-title":"Malignant pleural mesothelioma: An update on biomarkers and treatment","volume":"136","author":"Ray","year":"2009","journal-title":"Chest"},{"key":"10.1053\/j.ro.2013.03.017_bib52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib53","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/JTO.0b013e318269fe21","article-title":"Optimization of response classification criteria for patients with malignant pleural mesothelioma","volume":"7","author":"Labby","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-5223(98)70274-0","article-title":"Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma","volume":"115","author":"Pass","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: Stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"suppl 1","key":"10.1053\/j.ro.2013.03.017_bib56","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.lungcan.2005.03.006","article-title":"Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging","volume":"49","author":"Steinert","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11307-009-0203-6","article-title":"Prognostic value of 18F-FDG PET\/CT in patients with malignant pleural mesothelioma","volume":"11","author":"Lee","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.ro.2013.03.017_bib58","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2006.06.8999","article-title":"Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","article-title":"Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma","volume":"67","author":"Veit-Haibach","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1053\/j.ro.2013.03.017_bib60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JTO.0b013e3181cbf465","article-title":"Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma","volume":"5","author":"Tan","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib61","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.200802-258OC","article-title":"Soluble mesothelin-related protein in an asbestos-exposed population: The dust diseases board cohort study","volume":"178","author":"Park","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.ro.2013.03.017_bib62","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.200807-1125OC","article-title":"Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment","volume":"179","author":"Grigoriu","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.ro.2013.03.017_bib63","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/JTO.0b013e318180477b","article-title":"Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma","volume":"3","author":"Creaney","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.ro.2013.03.017_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiol.10092129","article-title":"CT findings of chemotherapy-induced toxicity: What radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity","volume":"258","author":"Torrisi","year":"2011","journal-title":"Radiology"},{"key":"10.1053\/j.ro.2013.03.017_bib65","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jtcvs.2007.11.022","article-title":"Postpneumonectomy syndrome: Surgical management and long-term results","volume":"135","author":"Shen","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.ro.2013.03.017_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.semtcvs.2009.06.011","article-title":"Current trends in radiologic management of malignant pleural mesothelioma","volume":"21","author":"Gill","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"}],"container-title":["Seminars in Roentgenology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037198X13000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037198X13000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T22:56:36Z","timestamp":1596495396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037198X13000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0037198X13000345"],"URL":"https:\/\/doi.org\/10.1053\/j.ro.2013.03.017","relation":{},"ISSN":["0037-198X"],"issn-type":[{"value":"0037-198X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}